Suven Life Sciences Ltd

  • BSE Code : 530239
  • NSE Symbol : SUVEN
  • ISIN : INE495B01038
  • Industry :MISCELLANEOUS

up-arrow 224.63 3.24(1.46%)

Open Price ()

224.29

Prev. Close ()

221.39

Volume (No’s)

179,307

Market Cap ()

5,109.75

Low Price ()

216.81

High Price ()

227.69

 

Book Closure

From Date To Date Announcement
01-Nov-2025 NA Outcome of the Meeting of Board of Directors of Suven Life Sciences Limited held on Tuesday, May 13, 2025
04-Sep-2025 NA Trading Members of the Exchange are hereby informed that the further new securities issued by the under mentioned companies are listed and admitted for trading on the Exchange with effect from Thursday, September 4, 2025 Name of the Company Suven Life Sciences Ltd. ISIN INE495B01038 Scrip Code 530239 No of shares 214000 Face Value 1 Dist Nos.From Dist Nos.To 227260208 227474207 Date upto which under lock-in NA
28-Aug-2025 NA Trading members of the Exchange are hereby informed that the under mentioned new securities of Suven Life Sciences Ltd. (Scrip Code - 530239) are listed and permitted to trade on the Exchange with effect from Thursday, August 28, 2025. Security Details 91,86,490 equity shares of Rs. 1/- each issued at a premium of Rs.133/- to Non Promoters on a preferential basis pursuant to conversion of warrants. These shares are ranking pari-passu with the old equity shares of the company. Dist. Nos. 218073718 to 227260207 Date of Allotment 16/07/2025 Issue Price Rs. 134/- ISIN INE495B01038
22-Aug-2025 NA Outcome of the Meeting of Board of Directors of Suven Life Sciences Limited held on Tuesday, May 13, 2025 Notice of 36th Annual General Meeting (As Per BSE Announcement Dated on :30.07.2025) 36th Annual General Meeting was held on 22nd August, 2025, summary of proceedings enclosed. (As per BSE Announcement Dated on 22/08/2025)
13-Aug-2025 NA Suven Life Sciences Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/08/2025 inter alia to consider and approve Un-audited Financial Results (Standalone and Consolidated) of the Company for the quarter ended June 30 2025 and related matters Financial Results Q1 FY 2025-26 (As Per BSE Announcement Dated on: 13.08.2025)

Copyright © 2024 Arihant Capital Markets Ltd. All rights Reserved.

Designed,Developed and Content powered by CMOTS Infotech (ISO 9001:2015 certified)

x
  • QR-CodeNew